[关键词]
[摘要]
目的 了解并分析2015—2017年辽宁省肿瘤医院门诊麻醉药品的临床应用及用药趋势,评价其合理性,为麻醉药品的规范管理和合理应用提供参考。方法 采用WHO推荐的限定日剂量(DDD)法对2017年2015—2017年辽宁省肿瘤医院门诊麻醉药品的规格、销量、销售金额、用药频度(DDDs)、日均费用(DDC))和排序比(B/A)等进行统计分析。结果 门诊麻醉药品的用量和销售金额逐年上升,结构日趋合理。盐酸羟考酮控释片和硫酸吗啡控释片的用量和DDDs逐年递增;芬太尼透皮贴剂和盐酸吗啡控释片的DDDs排序逐年下降。盐酸羟考酮控释片的DDC值最高,磷酸可待因片、阿片片和盐酸布桂嗪片的DDC值最低。2017年除盐酸吗啡片(30 mg)和盐酸羟考酮控释片(10 mg)外,其他药物的B/A值均接近1.00。结论 辽宁省肿瘤医院门诊麻醉药品的使用情况较为合理,但仍需加强管理。
[Key word]
[Abstract]
Objective To understand and analyze the clinical application and the trend of drug use of narcotic drugs in outpatient department of Liaoning Cancer Hospital from 2015 to 2017, and to evaluate its rationality and provide a reference for the standardized management and reasonable application of narcotic drugs.Methods The specifications, sales volume, consumption sum, frequency of drug use (DDDs), defined daily cost (DDC), and drug sequence ratio (B/A) of narcotic drugs in outpatient department of Liaoning Cancer Hospital from 2015 to 2017 were analyzed statistically according to the WHO-recommended DDD (defined daily dose) method. Results Consumption amount and sum of narcotic drugs in outpatient increased year by year, with the structure becoming more and more reasonable. The dosage and DDDs of Oxycodone Hydrochloride Controlled-release Tablets and Morphine Sulfate Controlled-release Tablets increased year by year, while DDDs of Fentanyl Transdermal Patches and Morphine Hydrochloride Modified-release Tablets decreased year by year. DDC of Oxycodone Hydrochloride Controlled-release Tablets was the highest, while DDC of Codeine Phosphate Tablets, Opium Tablets, and Bucinnazine Hydrochloride Tablets were the lowest. Except for Morphine Hydrochloride Tablets (30 mg) and Oxycodone Hydrochloride Controlled-release Tablets (10 mg), B/A of other narcotic drugs was next to 1.00. Conclusion The use of narcotic drugs in outpatient department of Liaoning Cancer Hospital is more reasonable, but still needs for strengthened management.
[中图分类号]
[基金项目]